<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181165</url>
  </required_header>
  <id_info>
    <org_study_id>H16-01539</org_study_id>
    <nct_id>NCT03181165</nct_id>
  </id_info>
  <brief_title>Pharmacist-led Therapeutic Nutritional Intervention in Type 2 Diabetes</brief_title>
  <official_title>Impact of a Pharmacist-led Therapeutic Nutritional Intervention on Medications and Glucose Control in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mitacs</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pharmasave</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes represents a significant burden to both the individual and our healthcare&#xD;
      system. Individuals with type 2 diabetes are typically prescribed one or more&#xD;
      glucose-lowering medications, many of which have undesirable side effects (e.g., nausea, risk&#xD;
      of cardiovascular complications, weight gain) and cost our healthcare system a lot of money.&#xD;
      An alternative strategy to lower blood glucose is to consume a low-carbohydrate diet.&#xD;
      However, adjusting medications after choosing to follow a low-carbohydrate diet can be&#xD;
      difficult. Delivering a low-carbohydrate diet through pharmacists could circumvent this&#xD;
      difficulty in medications adjustment because pharmacists are trained to adjust medications.&#xD;
      In this study the investigators will determine whether type 2 diabetes patients can reduce&#xD;
      medications and improve blood glucose by following a low-carbohydrate, low-calorie diet under&#xD;
      the direction of a pharmacist.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 5, 2017</start_date>
  <completion_date type="Actual">July 15, 2020</completion_date>
  <primary_completion_date type="Actual">November 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pragmatic effectiveness trial of diet intervention led by community pharmacists versus treatment-as-usual waitlist control.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Participants will know group assignments</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants not on glucose-lowering medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number of individuals taking no medications divided by the total number of participants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1C</measure>
    <time_frame>12 weeks</time_frame>
    <description>Blood test to measure glucose control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in glucose-lowering medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Reduction in total dose of glucose-lowering medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body mass in kilograms divided by height in meters squared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>12 weeks</time_frame>
    <description>Waist circumference in centimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body fat percentage measured by bioelectrical impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body mass in kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>12 weeks</time_frame>
    <description>Short-form (SF)-20 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in non-glucose lowering medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Dose of medications other than glucose-lowering</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipid profile</measure>
    <time_frame>12 weeks</time_frame>
    <description>triglycerides, HDL and LDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting insulin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting C-peptide</measure>
    <time_frame>12 weeks</time_frame>
    <description>fasting C-peptide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting high-sensitivity C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver enzymes</measure>
    <time_frame>12 weeks</time_frame>
    <description>liver alanine amino transferase, aspartate aminotransferase, gamma-gluatmyl transpeptidase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting plasma glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Systolic Blood Pressure measured by automatic cuff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Diastolic Blood Pressure measured by automatic cuff</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Habitual physical activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Godin leisure-time exercise questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Energy intake</measure>
    <time_frame>Baseline, 6 weeks, and 12 weeks</time_frame>
    <description>3-day diet record</description>
  </other_outcome>
  <other_outcome>
    <measure>Macronutrient intake</measure>
    <time_frame>Baseline, 6 weeks, and 12 weeks</time_frame>
    <description>3-day diet record</description>
  </other_outcome>
  <other_outcome>
    <measure>Intervention Satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <description>Satisfaction with intervention delivery questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">188</enrollment>
  <condition>Diet Modification</condition>
  <arm_group>
    <arm_group_label>Low-carbohydrate Therapeutic Nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 12-week low-carbohydrate, energy-restricted diet will be administered using a combination of pre-packaged foods and whole foods from pre-specified lists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment-as-usual waitlist control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive standard lifestyle advice to follow a low-fat, low-sugar, high fibre diet and aim to accumulate 150 minutes of moderate activity per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low-carbohydrate Therapeutic Nutrition</intervention_name>
    <description>The pharmacist or pharmacy lifestyle coach will work with the participant to develop a diet plan that is low in carbohydrate and energy-restricted based on personal preferences and characteristics. A combination of pre-packaged low-carbohydrate foods and whole foods from pre-specified lists will be used.</description>
    <arm_group_label>Low-carbohydrate Therapeutic Nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Between the ages of 30 and 75, have type 2 diabetes mellitus diagnosed by a physician, are&#xD;
        taking one or more glucose-lowering medications, have a BMI â‰¥30, have no contraindications&#xD;
        to following low-carbohydrate, energy-restricted, high-protein diet, and can read and speak&#xD;
        English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exlcusion criteria are:&#xD;
&#xD;
          1. Recent (within the last 2 years) diagnosis of coronary heart disease, stroke, or a&#xD;
             heart attack.&#xD;
&#xD;
          2. Unstable cardiovascular disorder.&#xD;
&#xD;
          3. History of liver disease.&#xD;
&#xD;
          4. History of kidney disease or impaired renal function.&#xD;
&#xD;
          5. Previously undergone bariatric surgery.&#xD;
&#xD;
          6. Multiple sclerosis or other diagnosed neurological disease.&#xD;
&#xD;
          7. Currently pregnant or lactating, or planning on becoming pregnant in the next 12&#xD;
             months.&#xD;
&#xD;
          8. Any form of cancer within the last 5 years.&#xD;
&#xD;
          9. Body mass index (BMI) of &lt;30.&#xD;
&#xD;
         10. Dietary restrictions that do not allow you to follow a low-carbohydrate,&#xD;
             energy-restricted, high-protein diet (e.g., vegan, food allergies).&#xD;
&#xD;
         11. Any sensitivities to the ingredients in the pre-packaged foods&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan P Little, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1V1V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Jonathan Little</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Low-carbohydrate</keyword>
  <keyword>Low calorie</keyword>
  <keyword>Energy restricted</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual values will be reported in figures if applicable.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

